A61K 47/69
The conjugate being characterised by physical or galenical forms
Official title: the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
A61K47/69 (The conjugate being characterised by physical or galenical forms) appears on 6,010 US grants and 10,463 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,010
- Published applications
- 10,463
- Assignees
- 3,560
- Inventors
- 18,746
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 10 | 0 |
| 1985 | 6 | 0 |
| 1986 | 10 | 0 |
| 1987 | 6 | 0 |
| 1988 | 12 | 0 |
| 1989 | 17 | 0 |
| 1990 | 8 | 0 |
| 1991 | 29 | 0 |
| 1992 | 25 | 0 |
| 1993 | 43 | 0 |
| 1994 | 39 | 0 |
| 1995 | 48 | 0 |
| 1996 | 75 | 0 |
| 1997 | 101 | 0 |
| 1998 | 111 | 0 |
| 1999 | 87 | 0 |
| 2000 | 94 | 0 |
| 2001 | 90 | 29 |
| 2002 | 89 | 154 |
| 2003 | 96 | 198 |
| 2004 | 69 | 205 |
| 2005 | 68 | 216 |
| 2006 | 88 | 203 |
| 2007 | 67 | 246 |
| 2008 | 60 | 236 |
| 2009 | 86 | 253 |
| 2010 | 105 | 350 |
| 2011 | 128 | 360 |
| 2012 | 167 | 342 |
| 2013 | 231 | 397 |
| 2014 | 229 | 415 |
| 2015 | 254 | 429 |
| 2016 | 266 | 459 |
| 2017 | 298 | 472 |
| 2018 | 279 | 555 |
| 2019 | 366 | 586 |
| 2020 | 376 | 642 |
| 2021 | 329 | 697 |
| 2022 | 305 | 696 |
| 2023 | 326 | 620 |
| 2024 | 326 | 638 |
| 2025 | 355 | 598 |
| 2026 | 224 | 467 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61K 47/6921The form being a particulate, a powder, an adsorbate, a bead or2,596
- A61K 47/6905The form being a colloid or an emulsion1,412
- A61K 47/6949Inclusion complexes1,152
- A61K 47/6901Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral672
- A61K 47/6903The form being semi-solid385
- A61K 47/6957The form being a device or a kit203
- A61K 47/6953The form being a fibre, a textile, a slab or a sheet58
- A61K 47/6955The form being a plaster, a bandage, a dressing or a patch14
All 9 subgroupsShow fewer
Recent patents
- Drug containing targeting liposomes6 Oct 2026US 12,752,016 B2Nextage Therapeutics Ltd.
- Therapeutic carbon nanomaterial H2S oxidants for biological polysulfide synthesis6 Oct 2026US 12,752,017 B2The Texas A&M University System
- Method for treating tumours by capturing copper and/or iron6 Oct 2026US 12,752,018 B2Centre National De La Recherche Scentifique (Cnrs)
- Treating vasculature related diseases or disorders using nanoparticles29 Sep 2026US 12,746,212 B2The Regents of the University of California
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- Extracellular vesicles for the delivery of payloads to eukaryotic cells8 Oct 2026US 2026/0306416 A1Alaya.bio Inc.
- Nanoparticles for photoimmune therapy comprising photosensitizer and adjuvant, and usage thereof8 Oct 2026US 2026/0306632 A1Korea Institute of Science and Technology
- Pharmaceutical compositions comprising meloxicam8 Oct 2026US 2026/0306635 A1Axsome Therapeutics, Inc.
- Process for purifying red blood cell membrane fragments8 Oct 2026US 2026/0306656 A1Ohio State Innovation Foundation
- Liposome conjugate targeting m2 macrophage and use thereof8 Oct 2026US 2026/0306657 A1Hangzhou Normal University
Most cited
By later US patents
- Polyhydroxyalkanoate compositions having controlled degradation rates1,516US 6,867,248 B1Metabolix, Inc. · 2005
- Medical scanning and treatment system and method1,502US 5,464,013 A1995
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Liposomes with enhanced circulation time1,198US 5,013,556 ALiposome Technology, Inc. · 1991
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998